nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—APOE—epilepsy syndrome	0.00665	0.031	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—APOE—epilepsy syndrome	0.00568	0.0265	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.00481	0.0224	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.00481	0.0224	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—ALB—epilepsy syndrome	0.00444	0.0207	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.00364	0.017	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—APOE—epilepsy syndrome	0.0034	0.0158	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.00333	0.0155	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.00321	0.0149	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.00291	0.0136	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CA13—epilepsy syndrome	0.00282	0.0132	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PDXK—epilepsy syndrome	0.00256	0.0119	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EPM2A—epilepsy syndrome	0.00234	0.0109	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NHLRC1—epilepsy syndrome	0.00234	0.0109	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PNPO—epilepsy syndrome	0.00234	0.0109	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.00227	0.0106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SV2A—epilepsy syndrome	0.00217	0.0101	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—FAR1—epilepsy syndrome	0.00214	0.00998	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ADK—epilepsy syndrome	0.00214	0.00998	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—L2HGDH—epilepsy syndrome	0.00214	0.00998	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GLUD1—epilepsy syndrome	0.00214	0.00998	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CERS1—epilepsy syndrome	0.00214	0.00998	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PDXK—epilepsy syndrome	0.00214	0.00998	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Phenobarbital—epilepsy syndrome	0.00212	0.0027	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Clonazepam—epilepsy syndrome	0.00212	0.0027	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Vigabatrin—epilepsy syndrome	0.00212	0.0027	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Clobazam—epilepsy syndrome	0.00212	0.00269	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Phenytoin—epilepsy syndrome	0.00211	0.00268	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.0021	0.00267	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Lacosamide—epilepsy syndrome	0.0021	0.00267	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Propofol—epilepsy syndrome	0.00209	0.00267	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Vigabatrin—epilepsy syndrome	0.00209	0.00266	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Levetiracetam—epilepsy syndrome	0.00209	0.00266	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Diazepam—epilepsy syndrome	0.00209	0.00266	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Rufinamide—epilepsy syndrome	0.00208	0.00265	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Lacosamide—epilepsy syndrome	0.00208	0.00265	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.00208	0.00265	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Lacosamide—epilepsy syndrome	0.00208	0.00264	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Vigabatrin—epilepsy syndrome	0.00208	0.00264	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Lacosamide—epilepsy syndrome	0.00206	0.00263	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Diazepam—epilepsy syndrome	0.00206	0.00262	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.00205	0.0026	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Acetazolamide—epilepsy syndrome	0.00205	0.0026	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Diazepam—epilepsy syndrome	0.00204	0.0026	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Topiramate—epilepsy syndrome	0.00204	0.0026	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Clobazam—epilepsy syndrome	0.00203	0.00259	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Levetiracetam—epilepsy syndrome	0.00202	0.00257	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Felbamate—epilepsy syndrome	0.00202	0.00257	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Clobazam—epilepsy syndrome	0.00202	0.00257	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Clobazam—epilepsy syndrome	0.00201	0.00257	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.00201	0.00256	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Clobazam—epilepsy syndrome	0.002	0.00255	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Felbamate—epilepsy syndrome	0.00199	0.00254	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Felbamate—epilepsy syndrome	0.00198	0.00252	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Zonisamide—epilepsy syndrome	0.00198	0.00252	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.00197	0.00251	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GAMT—epilepsy syndrome	0.00196	0.00913	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—EPM2A—epilepsy syndrome	0.00196	0.00913	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NHLRC1—epilepsy syndrome	0.00196	0.00913	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PNPO—epilepsy syndrome	0.00196	0.00913	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Lacosamide—epilepsy syndrome	0.00196	0.00249	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Zonisamide—epilepsy syndrome	0.00195	0.00248	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Acetazolamide—epilepsy syndrome	0.00195	0.00248	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.00194	0.00248	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.00194	0.00247	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.00194	0.00247	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PFKL—epilepsy syndrome	0.00194	0.00903	CbGpPWpGaD
Glycerol Phenylbutyrate—Fatigue—Zonisamide—epilepsy syndrome	0.00194	0.00246	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Valproic Acid—epilepsy syndrome	0.00193	0.00246	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Clonazepam—epilepsy syndrome	0.0019	0.00242	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Vigabatrin—epilepsy syndrome	0.0019	0.00242	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Valproic Acid—epilepsy syndrome	0.0019	0.00242	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Clobazam—epilepsy syndrome	0.0019	0.00242	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Propofol—epilepsy syndrome	0.0019	0.00242	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Phenytoin—epilepsy syndrome	0.00189	0.00241	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Acetazolamide—epilepsy syndrome	0.00189	0.0024	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.00188	0.0024	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Clonazepam—epilepsy syndrome	0.00188	0.00239	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.00188	0.00239	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Diazepam—epilepsy syndrome	0.00187	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Phenytoin—epilepsy syndrome	0.00187	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.00187	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Clonazepam—epilepsy syndrome	0.00187	0.00237	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Midazolam—epilepsy syndrome	0.00186	0.00237	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.00186	0.00237	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.00186	0.00236	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Phenytoin—epilepsy syndrome	0.00185	0.00236	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Topiramate—epilepsy syndrome	0.00185	0.00236	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.00185	0.00235	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Oxcarbazepine—epilepsy syndrome	0.00184	0.00235	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.00184	0.00234	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Levetiracetam—epilepsy syndrome	0.00184	0.00234	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—QDPR—epilepsy syndrome	0.00182	0.00848	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CA4—epilepsy syndrome	0.00182	0.00848	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Felbamate—epilepsy syndrome	0.00181	0.00231	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Acetazolamide—epilepsy syndrome	0.00181	0.00231	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Propofol—epilepsy syndrome	0.00181	0.00231	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Carbamazepine—epilepsy syndrome	0.00181	0.0023	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Acetazolamide—epilepsy syndrome	0.00179	0.00227	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Carbamazepine—epilepsy syndrome	0.00178	0.00227	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Zonisamide—epilepsy syndrome	0.00177	0.00226	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—STX1B—epilepsy syndrome	0.00177	0.00826	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Fosphenytoin—epilepsy syndrome	0.00177	0.00226	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.00177	0.00225	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.00177	0.00225	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Carbamazepine—epilepsy syndrome	0.00177	0.00225	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Propofol—epilepsy syndrome	0.00175	0.00223	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Levetiracetam—epilepsy syndrome	0.00175	0.00223	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.00175	0.00223	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Lamotrigine—epilepsy syndrome	0.00175	0.00222	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Pregabalin—epilepsy syndrome	0.00175	0.00222	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Vigabatrin—epilepsy syndrome	0.00173	0.0022	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Lamotrigine—epilepsy syndrome	0.00172	0.00219	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Pregabalin—epilepsy syndrome	0.00172	0.00219	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Midazolam—epilepsy syndrome	0.00171	0.00218	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.00171	0.00218	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—COX3—epilepsy syndrome	0.00171	0.00798	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Clonazepam—epilepsy syndrome	0.00171	0.00218	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Lamotrigine—epilepsy syndrome	0.00171	0.00218	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Diazepam—epilepsy syndrome	0.0017	0.00216	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Acetazolamide—epilepsy syndrome	0.00169	0.00216	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Levetiracetam—epilepsy syndrome	0.00169	0.00215	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.00169	0.00215	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.00169	0.00215	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Propofol—epilepsy syndrome	0.00168	0.00214	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.00168	0.00214	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Propofol—epilepsy syndrome	0.00167	0.00213	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Propofol—epilepsy syndrome	0.00167	0.00212	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Propofol—epilepsy syndrome	0.00166	0.00211	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Midazolam—epilepsy syndrome	0.00165	0.0021	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CPSF4—epilepsy syndrome	0.00165	0.00768	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—GBE1—epilepsy syndrome	0.00165	0.00768	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PPP1R3C—epilepsy syndrome	0.00165	0.00768	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Vigabatrin—epilepsy syndrome	0.00165	0.0021	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Felbamate—epilepsy syndrome	0.00165	0.00209	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRDM4—epilepsy syndrome	0.00164	0.00763	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.00164	0.00763	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Midazolam—epilepsy syndrome	0.00163	0.00208	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Fosphenytoin—epilepsy syndrome	0.00163	0.00208	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Midazolam—epilepsy syndrome	0.00163	0.00208	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Levetiracetam—epilepsy syndrome	0.00163	0.00207	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Midazolam—epilepsy syndrome	0.00162	0.00207	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CACNA2D2—epilepsy syndrome	0.00162	0.00756	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLCO1A2—epilepsy syndrome	0.00162	0.00756	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—KCNB1—epilepsy syndrome	0.00162	0.00756	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PFKL—epilepsy syndrome	0.00162	0.00756	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC6A8—epilepsy syndrome	0.00162	0.00756	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Carbamazepine—epilepsy syndrome	0.00162	0.00206	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Diazepam—epilepsy syndrome	0.00162	0.00206	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.00162	0.00206	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Levetiracetam—epilepsy syndrome	0.00161	0.00205	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Levetiracetam—epilepsy syndrome	0.00161	0.00205	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Zonisamide—epilepsy syndrome	0.00161	0.00205	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Levetiracetam—epilepsy syndrome	0.0016	0.00204	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Gabapentin—epilepsy syndrome	0.0016	0.00204	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Vigabatrin—epilepsy syndrome	0.00159	0.00203	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	0.00159	0.00739	CbGpPWpGaD
Glycerol Phenylbutyrate—Flatulence—Gabapentin—epilepsy syndrome	0.00158	0.00201	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	0.00158	0.00735	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Propofol—epilepsy syndrome	0.00157	0.002	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Fosphenytoin—epilepsy syndrome	0.00157	0.002	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Felbamate—epilepsy syndrome	0.00157	0.002	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Lamotrigine—epilepsy syndrome	0.00157	0.002	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Diazepam—epilepsy syndrome	0.00157	0.00199	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Fosphenytoin—epilepsy syndrome	0.00156	0.00198	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Fosphenytoin—epilepsy syndrome	0.00156	0.00198	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Clonazepam—epilepsy syndrome	0.00155	0.00198	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Fosphenytoin—epilepsy syndrome	0.00155	0.00197	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.00154	0.00197	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Phenytoin—epilepsy syndrome	0.00154	0.00196	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Midazolam—epilepsy syndrome	0.00154	0.00196	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Zonisamide—epilepsy syndrome	0.00154	0.00196	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Oxcarbazepine—epilepsy syndrome	0.00153	0.00195	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Vigabatrin—epilepsy syndrome	0.00153	0.00195	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Levetiracetam—epilepsy syndrome	0.00152	0.00193	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Vigabatrin—epilepsy syndrome	0.00152	0.00193	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Felbamate—epilepsy syndrome	0.00152	0.00193	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Vigabatrin—epilepsy syndrome	0.00152	0.00193	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Vigabatrin—epilepsy syndrome	0.00151	0.00192	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Diazepam—epilepsy syndrome	0.00151	0.00192	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Diazepam—epilepsy syndrome	0.00149	0.0019	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Diazepam—epilepsy syndrome	0.00149	0.0019	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Zonisamide—epilepsy syndrome	0.00148	0.00189	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Diazepam—epilepsy syndrome	0.00148	0.00189	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—UPB1—epilepsy syndrome	0.00148	0.00692	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ATIC—epilepsy syndrome	0.00148	0.00692	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NEU1—epilepsy syndrome	0.00148	0.00692	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Clonazepam—epilepsy syndrome	0.00148	0.00188	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Carbamazepine—epilepsy syndrome	0.00147	0.00187	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Phenytoin—epilepsy syndrome	0.00147	0.00187	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Fosphenytoin—epilepsy syndrome	0.00147	0.00187	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.00146	0.00186	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Felbamate—epilepsy syndrome	0.00146	0.00186	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Felbamate—epilepsy syndrome	0.00145	0.00184	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Felbamate—epilepsy syndrome	0.00144	0.00184	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Felbamate—epilepsy syndrome	0.00144	0.00183	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ACKR4—epilepsy syndrome	0.00143	0.00667	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Clonazepam—epilepsy syndrome	0.00143	0.00182	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Vigabatrin—epilepsy syndrome	0.00143	0.00182	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSD17B4—epilepsy syndrome	0.00143	0.00666	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Zonisamide—epilepsy syndrome	0.00143	0.00182	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Lamotrigine—epilepsy syndrome	0.00142	0.00181	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Phenytoin—epilepsy syndrome	0.00142	0.00181	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Zonisamide—epilepsy syndrome	0.00142	0.0018	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Zonisamide—epilepsy syndrome	0.00141	0.0018	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Oxcarbazepine—epilepsy syndrome	0.00141	0.0018	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Diazepam—epilepsy syndrome	0.00141	0.00179	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Zonisamide—epilepsy syndrome	0.00141	0.00179	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Carbamazepine—epilepsy syndrome	0.0014	0.00179	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Pregabalin—epilepsy syndrome	0.0014	0.00178	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Valproic Acid—epilepsy syndrome	0.00139	0.00177	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GBE1—epilepsy syndrome	0.00138	0.00643	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPP1R3C—epilepsy syndrome	0.00138	0.00643	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Clonazepam—epilepsy syndrome	0.00138	0.00175	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ST3GAL3—epilepsy syndrome	0.00137	0.00639	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Valproic Acid—epilepsy syndrome	0.00137	0.00174	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Phenytoin—epilepsy syndrome	0.00137	0.00174	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Clonazepam—epilepsy syndrome	0.00136	0.00174	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Clonazepam—epilepsy syndrome	0.00136	0.00174	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Felbamate—epilepsy syndrome	0.00136	0.00173	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.00136	0.00173	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Oxcarbazepine—epilepsy syndrome	0.00136	0.00173	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Valproic Acid—epilepsy syndrome	0.00136	0.00173	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Carbamazepine—epilepsy syndrome	0.00136	0.00173	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Lamotrigine—epilepsy syndrome	0.00136	0.00173	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Clonazepam—epilepsy syndrome	0.00136	0.00173	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Phenytoin—epilepsy syndrome	0.00136	0.00173	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Phenytoin—epilepsy syndrome	0.00135	0.00172	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.00135	0.00628	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Oxcarbazepine—epilepsy syndrome	0.00135	0.00172	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.00135	0.00171	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Phenytoin—epilepsy syndrome	0.00135	0.00171	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Topiramate—epilepsy syndrome	0.00135	0.00171	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Oxcarbazepine—epilepsy syndrome	0.00134	0.0017	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Zonisamide—epilepsy syndrome	0.00133	0.0017	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Topiramate—epilepsy syndrome	0.00133	0.00169	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Lamotrigine—epilepsy syndrome	0.00131	0.00167	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Carbamazepine—epilepsy syndrome	0.0013	0.00166	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ASAH1—epilepsy syndrome	0.0013	0.00605	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SSTR5—epilepsy syndrome	0.00129	0.00603	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SSTR4—epilepsy syndrome	0.00129	0.00603	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Carbamazepine—epilepsy syndrome	0.00129	0.00165	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Carbamazepine—epilepsy syndrome	0.00129	0.00165	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.00129	0.00164	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Clonazepam—epilepsy syndrome	0.00129	0.00164	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Carbamazepine—epilepsy syndrome	0.00129	0.00164	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Gabapentin—epilepsy syndrome	0.00128	0.00163	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Phenytoin—epilepsy syndrome	0.00128	0.00163	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Oxcarbazepine—epilepsy syndrome	0.00127	0.00162	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—STXBP1—epilepsy syndrome	0.00126	0.00588	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Lamotrigine—epilepsy syndrome	0.00126	0.0016	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Lamotrigine—epilepsy syndrome	0.00125	0.00159	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Lamotrigine—epilepsy syndrome	0.00125	0.00159	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Valproic Acid—epilepsy syndrome	0.00125	0.00159	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Lamotrigine—epilepsy syndrome	0.00124	0.00158	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR10—epilepsy syndrome	0.00124	0.00578	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Pregabalin—epilepsy syndrome	0.00124	0.00158	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.00123	0.00157	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NT5E—epilepsy syndrome	0.00123	0.00573	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALAD—epilepsy syndrome	0.00123	0.00573	CbGpPWpGaD
Glycerol Phenylbutyrate—Fatigue—Pregabalin—epilepsy syndrome	0.00123	0.00156	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Carbamazepine—epilepsy syndrome	0.00122	0.00155	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Lamotrigine—epilepsy syndrome	0.00118	0.0015	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CACNA1A—epilepsy syndrome	0.00117	0.00547	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALDH7A1—epilepsy syndrome	0.00117	0.00547	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.00116	0.00148	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Gabapentin—epilepsy syndrome	0.00115	0.00146	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ST3GAL3—epilepsy syndrome	0.00115	0.00535	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Gabapentin—epilepsy syndrome	0.00114	0.00145	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Valproic Acid—epilepsy syndrome	0.00113	0.00144	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.00113	0.00144	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Gabapentin—epilepsy syndrome	0.00113	0.00143	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Pregabalin—epilepsy syndrome	0.00113	0.00143	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ADSL—epilepsy syndrome	0.00112	0.00524	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GLUL—epilepsy syndrome	0.0011	0.00514	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRM2—epilepsy syndrome	0.00108	0.00506	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CACNA1D—epilepsy syndrome	0.00108	0.00505	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Valproic Acid—epilepsy syndrome	0.00108	0.00137	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Topiramate—epilepsy syndrome	0.00108	0.00137	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.00107	0.00136	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Valproic Acid—epilepsy syndrome	0.00104	0.00133	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Gabapentin—epilepsy syndrome	0.00103	0.00131	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Pregabalin—epilepsy syndrome	0.00102	0.0013	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TXNRD1—epilepsy syndrome	0.00101	0.00472	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Valproic Acid—epilepsy syndrome	0.001	0.00128	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—EIF2AK2—epilepsy syndrome	0.000998	0.00465	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Valproic Acid—epilepsy syndrome	0.000993	0.00126	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Valproic Acid—epilepsy syndrome	0.000992	0.00126	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Valproic Acid—epilepsy syndrome	0.000987	0.00126	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AQP1—epilepsy syndrome	0.000983	0.00458	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SSTR3—epilepsy syndrome	0.000981	0.00457	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Pregabalin—epilepsy syndrome	0.000975	0.00124	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Topiramate—epilepsy syndrome	0.000967	0.00123	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.00096	0.00447	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Topiramate—epilepsy syndrome	0.000955	0.00122	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000949	0.00121	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Topiramate—epilepsy syndrome	0.000947	0.00121	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.000944	0.0044	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Pregabalin—epilepsy syndrome	0.000942	0.0012	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.00094	0.00438	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NPY2R—epilepsy syndrome	0.00094	0.00438	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SSTR1—epilepsy syndrome	0.00094	0.00438	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR8—epilepsy syndrome	0.00094	0.00438	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR9—epilepsy syndrome	0.00094	0.00438	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Gabapentin—epilepsy syndrome	0.000937	0.00119	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Valproic Acid—epilepsy syndrome	0.000936	0.00119	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PPIA—epilepsy syndrome	0.000923	0.0043	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRM3—epilepsy syndrome	0.000922	0.0043	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRM4—epilepsy syndrome	0.000922	0.0043	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Pregabalin—epilepsy syndrome	0.000906	0.00115	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DUSP4—epilepsy syndrome	0.000905	0.00422	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SSTR2—epilepsy syndrome	0.000905	0.00422	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000898	0.00114	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Pregabalin—epilepsy syndrome	0.000898	0.00114	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Pregabalin—epilepsy syndrome	0.000897	0.00114	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Gabapentin—epilepsy syndrome	0.000894	0.00114	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Pregabalin—epilepsy syndrome	0.000892	0.00114	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—KCNJ11—epilepsy syndrome	0.000889	0.00414	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CHRM3—epilepsy syndrome	0.000889	0.00414	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRM8—epilepsy syndrome	0.000874	0.00407	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PGF—epilepsy syndrome	0.000874	0.00407	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Topiramate—epilepsy syndrome	0.000869	0.00111	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Gabapentin—epilepsy syndrome	0.000864	0.0011	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Pregabalin—epilepsy syndrome	0.000846	0.00108	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—OPRD1—epilepsy syndrome	0.000834	0.00389	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GNAO1—epilepsy syndrome	0.000834	0.00389	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Gabapentin—epilepsy syndrome	0.00083	0.00106	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.000828	0.00386	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Gabapentin—epilepsy syndrome	0.000823	0.00105	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Gabapentin—epilepsy syndrome	0.000823	0.00105	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Gabapentin—epilepsy syndrome	0.000818	0.00104	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.000811	0.00378	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR7—epilepsy syndrome	0.0008	0.00373	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CHRM1—epilepsy syndrome	0.0008	0.00373	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRM1—epilepsy syndrome	0.0008	0.00373	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PDYN—epilepsy syndrome	0.0008	0.00373	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Topiramate—epilepsy syndrome	0.000788	0.001	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Gabapentin—epilepsy syndrome	0.000776	0.000988	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Topiramate—epilepsy syndrome	0.000752	0.000957	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GAL—epilepsy syndrome	0.000752	0.0035	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GFAP—epilepsy syndrome	0.000752	0.0035	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRM5—epilepsy syndrome	0.000743	0.00346	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CHRM3—epilepsy syndrome	0.000743	0.00346	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CASP2—epilepsy syndrome	0.000743	0.00346	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Topiramate—epilepsy syndrome	0.000727	0.000925	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCG2—epilepsy syndrome	0.000725	0.00338	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000713	0.00332	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP2C19—epilepsy syndrome	0.000706	0.00329	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP11A1—epilepsy syndrome	0.000702	0.00327	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CHRM2—epilepsy syndrome	0.000699	0.00326	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000699	0.00326	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000699	0.00326	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Topiramate—epilepsy syndrome	0.000699	0.000889	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	0.000697	0.00325	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Topiramate—epilepsy syndrome	0.000693	0.000882	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Topiramate—epilepsy syndrome	0.000692	0.000881	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Topiramate—epilepsy syndrome	0.000688	0.000876	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC2A1—epilepsy syndrome	0.000684	0.00319	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GABBR1—epilepsy syndrome	0.00068	0.00317	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—JUNB—epilepsy syndrome	0.000679	0.00316	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS1—epilepsy syndrome	0.000674	0.00314	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Topiramate—epilepsy syndrome	0.000653	0.000831	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HRH3—epilepsy syndrome	0.000652	0.00304	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HBEGF—epilepsy syndrome	0.000643	0.003	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—OPRM1—epilepsy syndrome	0.000642	0.00299	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	0.000635	0.00296	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP2D6—epilepsy syndrome	0.000633	0.00295	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT3—epilepsy syndrome	0.000631	0.00294	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ADAM10—epilepsy syndrome	0.000617	0.00287	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR3—epilepsy syndrome	0.000606	0.00282	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ADRA2A—epilepsy syndrome	0.000603	0.00281	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—BCHE—epilepsy syndrome	0.0006	0.0028	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NPY—epilepsy syndrome	0.00059	0.00275	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ATP2A2—epilepsy syndrome	0.00059	0.00275	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDC42—epilepsy syndrome	0.000576	0.00268	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC2A1—epilepsy syndrome	0.000573	0.00267	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HSPB1—epilepsy syndrome	0.00057	0.00266	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL3—epilepsy syndrome	0.00057	0.00266	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL2—epilepsy syndrome	0.00057	0.00266	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CRH—epilepsy syndrome	0.00057	0.00266	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—OXT—epilepsy syndrome	0.00057	0.00266	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PLCB1—epilepsy syndrome	0.000567	0.00264	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TH—epilepsy syndrome	0.000565	0.00263	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	0.000556	0.00259	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TSC1—epilepsy syndrome	0.00053	0.00247	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTK2B—epilepsy syndrome	0.00053	0.00247	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HES1—epilepsy syndrome	0.000527	0.00246	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR2—epilepsy syndrome	0.000515	0.0024	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NTRK2—epilepsy syndrome	0.000515	0.0024	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SST—epilepsy syndrome	0.000515	0.0024	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FYN—epilepsy syndrome	0.000513	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—H2AFX—epilepsy syndrome	0.000511	0.00238	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DUSP6—epilepsy syndrome	0.000511	0.00238	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000504	0.00235	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PLAT—epilepsy syndrome	0.000502	0.00234	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—YWHAZ—epilepsy syndrome	0.000493	0.0023	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL12—epilepsy syndrome	0.000484	0.00226	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000484	0.00226	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JUNB—epilepsy syndrome	0.000475	0.00222	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CNR1—epilepsy syndrome	0.000475	0.00222	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CCR5—epilepsy syndrome	0.000474	0.00221	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PLCB1—epilepsy syndrome	0.000474	0.00221	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HMOX1—epilepsy syndrome	0.000471	0.0022	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CAT—epilepsy syndrome	0.000465	0.00217	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HTR7—epilepsy syndrome	0.000464	0.00216	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCB1—epilepsy syndrome	0.000452	0.00211	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HBEGF—epilepsy syndrome	0.00045	0.0021	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT3—epilepsy syndrome	0.000442	0.00206	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TSC2—epilepsy syndrome	0.000441	0.00205	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADAM10—epilepsy syndrome	0.000432	0.00201	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOE—epilepsy syndrome	0.000431	0.00201	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GPX1—epilepsy syndrome	0.00042	0.00196	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—S100B—epilepsy syndrome	0.000408	0.0019	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6ST—epilepsy syndrome	0.000405	0.00189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SOCS3—epilepsy syndrome	0.000404	0.00188	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDC42—epilepsy syndrome	0.000403	0.00188	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS2—epilepsy syndrome	0.000402	0.00187	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AVP—epilepsy syndrome	0.00039	0.00182	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HES1—epilepsy syndrome	0.000369	0.00172	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AGT—epilepsy syndrome	0.000369	0.00172	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOE—epilepsy syndrome	0.000361	0.00168	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FYN—epilepsy syndrome	0.000359	0.00167	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—H2AFX—epilepsy syndrome	0.000358	0.00167	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MEF2C—epilepsy syndrome	0.000357	0.00166	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000345	0.00161	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NGF—epilepsy syndrome	0.000341	0.00159	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR5—epilepsy syndrome	0.000332	0.00155	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF2—epilepsy syndrome	0.000328	0.00153	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HTR2A—epilepsy syndrome	0.000325	0.00151	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—POMC—epilepsy syndrome	0.00031	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TSC2—epilepsy syndrome	0.000309	0.00144	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AGT—epilepsy syndrome	0.000308	0.00144	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOE—epilepsy syndrome	0.000302	0.00141	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTOR—epilepsy syndrome	0.000298	0.00139	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KDR—epilepsy syndrome	0.000296	0.00138	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTGS2—epilepsy syndrome	0.000296	0.00138	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKCB—epilepsy syndrome	0.000285	0.00133	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6ST—epilepsy syndrome	0.000284	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALB—epilepsy syndrome	0.000283	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—POMC—epilepsy syndrome	0.000259	0.00121	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL2—epilepsy syndrome	0.000254	0.00118	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTGS2—epilepsy syndrome	0.000248	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SRC—epilepsy syndrome	0.000239	0.00111	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF2—epilepsy syndrome	0.000229	0.00107	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RELA—epilepsy syndrome	0.000213	0.000993	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MTOR—epilepsy syndrome	0.000209	0.000974	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CASP3—epilepsy syndrome	0.000192	0.000895	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JUN—epilepsy syndrome	0.000187	0.00087	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP9—epilepsy syndrome	0.000182	0.000846	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SRC—epilepsy syndrome	0.000167	0.00078	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFA—epilepsy syndrome	0.000163	0.00076	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT1—epilepsy syndrome	0.000149	0.000692	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKT1—epilepsy syndrome	0.000124	0.00058	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT1—epilepsy syndrome	0.000104	0.000485	CbGpPWpGaD
